Home › Overactive Bladder › NCT07178314
At-Home Transcutaneous Tibial Nerve Stimulation for Overactive Bladder in Rural Women
Evaluating the Feasibility and Efficacy of At-Home Transcutaneous Tibial Nerve Stimulation (TTNS) for Overactive Bladder in Rural Women
Who can join
Ages 18 and older · Women
Full eligibility criteria
Inclusion Criteria: * Rural residence (as defined by the Federal Office of Rural Health policy confirmed with the "Am I rural?" tool) * Clinical diagnosis of overactive bladder (OAB) with urinary frequency \>= 8 times per day * Able to complete questionnaires, urination diaries, and interview in English or Spanish * Have reliable access to a telephone or email for communication * Ambulatory and able to use the toilet independently Exclusion Criteria: * Unable to consent * Pregnancy or planning to become pregnant during the study period * Previous treatment for OAB including medication, intravesical botox, and/or neuromodulation use * Presence of pacemaker or implantable defibrillator * Indwelling metal in both ankles * Presence of leg ulcers, open wounds, or skin conditions affecting lower legs * Absence of sensation in the lower legs * Active urinary tract infection * Predominantly stress urinary incontinence * Active malignancy * Neurogenic bladder * Subjective complaint of pelvic organ prolapse outside of vaginal introitus * Subjective symptoms of incomplete bladder emptying * Epilepsy * Peripheral artery disease affecting both legs
About the study
This study contains a mixed-methods design consisting of a single-arm, interventional study and prospective patient interviews evaluating a novel self-implemented at-home Transcutaneous Tibial Nerve Stimulation (TTNS) treatment protocol for management of treatment naïve overactive bladder (OAB) among rural-dwelling women. This study will be conducted in 3 rural Oregon communities where Oregon Health \& Science University satellite campuses are located.
What is being tested
- Transcutaneous Tibial Nerve Stimulation (TTNS) (device)
Sponsor: Oregon Health and Science University · Participants: 38 · Started: Oct 6, 2025
Contact the study team
- Women's Health Research Unit Department of Ob/Gyn · Phone: 503-494-3666
Official record on ClinicalTrials.gov — NCT07178314
Locations in the U.S.
| Oregon | Oregon Health & Science University, Portland |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.